banner2

Getting started
Methyl 3-Amino-2-Pyrazinecarboxylate CAS 16298-03-6

Methyl 3-Amino-2-Pyrazinecarboxylate CAS 16298-03-6 - Manufacturers, Suppliers, Factory from China

Methyl 3-Amino-2-Pyrazinecarboxylate CAS 16298-03-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Methyl 3-Amino-2-Pyrazinecarboxylate CAS 16298-03-6 Purity 98.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Methyl 3-Amino-2-Pyrazinecarboxylate CAS 16298-03-6 Purity >98.0% (GC)
Read More

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

DL-Proline Methyl Ester Hydrochloride CAS 79397-50-5 Assay ≥98.0% (TLC)

D-Phenylalanine Methyl Ester Hydrochloride CAS 13033-84-6 Assay ≥98.0% (HPLC)

D-Glutamic Acid Dimethyl Ester Hydrochloride CAS 27025-25-8 Assay ≥99.0% (Titration)

D-Lysine Methyl Ester Dihydrochloride CAS 67396-08-1 Assay ≥98.0% (Titration)

D-Norleucine Methyl Ester Hydrochloride CAS 60687-33-4 Assay ≥98.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...

2022.12.12 10:08:19
2022.07.10 09:38:42
2022.07.08 01:17:51
2022.01.10 01:04:41
2021.12.30 06:16:28
2021.12.24 19:57:36

related search